{"podcast":{"title":"CNBC’s “Money Movers”","slug":"cnbc-s-money-movers-6706747","podcast_index_feed_id":6706747,"rss_url":"https://feeds.simplecast.com/VIBW5IOj","website_url":"https://www.cnbc.com","image_url":"https://image.simplecastcdn.com/images/92728f12-3d53-46b8-9a33-60e9b83ad72d/01931e77-bcba-4bab-b7e9-8fd5916efc6a/3000x3000/money-movers-podcast-cover-art-3000x3000-v03.jpg?aid=rss_feed","author":"CNBC","episode_count":611,"summary":"“Money Movers” provides investors with real-time analysis of the stories and the people attracting the attention of the markets each day. Capturing the energy of day’s early trading, the program includes the breaking news and numbers driving stocks and sectors, helping investors make critical decisions. “Money Movers” anchors speak with the CEOs, government decision-makers and newsmakers who play a relevant role in how money is moving.","last_synced_at":null,"page_url":"https://stenobird.com/podcast/cnbc-s-money-movers-6706747"},"episode":{"title":"Benchmark’s Bill Gurley, CoreWeave Strikes Deal with Anthropic, New Treatment for Pancreatic Cancer 4/10/26","slug":"benchmark-s-bill-gurley-coreweave-strikes-deal-with-anthropic-new-treatment-for-pancreatic-cancer-4-10-26","published_at":"2026-04-10T16:13:26+00:00","page_url":"https://stenobird.com/podcast/cnbc-s-money-movers-6706747/benchmark-s-bill-gurley-coreweave-strikes-deal-with-anthropic-new-treatment-for-pancreatic-cancer-4-10-26","show_page_url":"https://stenobird.com/podcast/cnbc-s-money-movers-6706747","url":"https://www.cnbc.com","audio_url":"https://dts.podtrac.com/redirect.mp3/cnbc.simplecastaudio.com/3b3ace90-e7b6-4c5f-b15f-fa937b6962eb/episodes/8922dee9-3baa-48a7-870b-6e88fca9024e/audio/128/default.mp3?aid=rss_feed&awCollectionId=3b3ace90-e7b6-4c5f-b15f-fa937b6962eb&awEpisodeId=8922dee9-3baa-48a7-870b-6e88fca9024e&feed=VIBW5IOj","summary":"Concerns grow over AI’s cyber security risks with the Fed Chair and Treasury Secretary meeting with bank executives. Legendary investor Bill Gurley lays out his thoughts on the rapidly changing landscape. Then CoreWeave inking yet another deal with a major AI player, this time Anthropic. We look at the bull and bear cases for the stock. And a new treatment from Revolution Medicines targets one of the deadliest forms of cancer, pancreatic.","meta_description":"Concerns grow over AI’s cyber security risks with the Fed Chair and Treasury Secretary meeting with bank executives. Legendary investor Bill Gurley lays o…","key_points":[],"chapters":[],"topics":[],"duration_seconds":2542,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/cnbc-s-money-movers-6706747/episodes/benchmark-s-bill-gurley-coreweave-strikes-deal-with-anthropic-new-treatment-for-pancreatic-cancer-4-10-26/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/cnbc-s-money-movers-6706747/benchmark-s-bill-gurley-coreweave-strikes-deal-with-anthropic-new-treatment-for-pancreatic-cancer-4-10-26.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}